secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001641172-25-011183
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals announces 1-for-15 reverse stock split effective May 19, 2025
--------------------------------------------------------------------------------

- 1-for-15 reverse split effective May 19, 2025 at 5:00 p.m. ET; split-adjusted trading begins May 20 under ticker CDT.
- Post-split outstanding shares reduced to approximately 755,900 from roughly 11.3 million pre-split.
- No fractional shares issued; cash payment in lieu at closing price on May 19.
- Par value unchanged at $0.0001; new CUSIP number 20678X 304; warrants and equity awards proportionally adjusted.
- Stockholders approved reverse split at special meeting on May 5, 2025; board set exact ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225011183/0001641172-25-011183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225011183/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer